A Case of Screening Macroprolactinemia Using Polyethylene Glycol Precipitation Method.

IF 0.7 4区 医学 Q4 MEDICAL LABORATORY TECHNOLOGY
Gangfeng Li, Ningping Shan, Qian Wang
{"title":"A Case of Screening Macroprolactinemia Using Polyethylene Glycol Precipitation Method.","authors":"Gangfeng Li, Ningping Shan, Qian Wang","doi":"10.7754/Clin.Lab.2024.241008","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Hyperprolactinemia is an endocrine disorder characterized by abnormally elevated levels of prolactin (PRL) in the serum. Macroprolactinemia refers to the condition where more than 60% of the prolactin circulating in the peripheral blood is composed of high molecular weight macroprolactins. These macroprolactins typically have low biological activity but can lead to a false increase in serum prolactin levels.</p><p><strong>Methods: </strong>We report a case of pseudoelevation of prolactin caused by macroprolactin. We used pituitary MRI and other examinations to identify the cause of elevated serum prolactin levels and different detection platforms and polyethylene glycol (PEG) precipitation method to screen for the possibility of pseudo elevation of prolactin caused by macroprolactin.</p><p><strong>Results: </strong>Whether measured using two different testing platforms or using our own testing platform after sample pretreatment with PEG, serum prolactin levels were within the normal range. Therefore, based on the negative results of pituitary MRI, we believe that the patient's pseudo elevation of serum prolactin is caused by interference from macroprolactin.</p><p><strong>Conclusions: </strong>When there is an abnormal increase in serum prolactin but no evidence of related clinical symptoms, staff should consider the possibility of macroprolactin interfering with prolactin testing, take corresponding corrective measures, and avoid unnecessary examinations and treatments for patients.</p>","PeriodicalId":10384,"journal":{"name":"Clinical laboratory","volume":"71 3","pages":""},"PeriodicalIF":0.7000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical laboratory","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.7754/Clin.Lab.2024.241008","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"MEDICAL LABORATORY TECHNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Hyperprolactinemia is an endocrine disorder characterized by abnormally elevated levels of prolactin (PRL) in the serum. Macroprolactinemia refers to the condition where more than 60% of the prolactin circulating in the peripheral blood is composed of high molecular weight macroprolactins. These macroprolactins typically have low biological activity but can lead to a false increase in serum prolactin levels.

Methods: We report a case of pseudoelevation of prolactin caused by macroprolactin. We used pituitary MRI and other examinations to identify the cause of elevated serum prolactin levels and different detection platforms and polyethylene glycol (PEG) precipitation method to screen for the possibility of pseudo elevation of prolactin caused by macroprolactin.

Results: Whether measured using two different testing platforms or using our own testing platform after sample pretreatment with PEG, serum prolactin levels were within the normal range. Therefore, based on the negative results of pituitary MRI, we believe that the patient's pseudo elevation of serum prolactin is caused by interference from macroprolactin.

Conclusions: When there is an abnormal increase in serum prolactin but no evidence of related clinical symptoms, staff should consider the possibility of macroprolactin interfering with prolactin testing, take corresponding corrective measures, and avoid unnecessary examinations and treatments for patients.

聚乙二醇沉淀法筛选大催乳素血症1例。
背景:高催乳素血症是一种以血清中催乳素(PRL)水平异常升高为特征的内分泌紊乱。大催乳素血症是指外周血循环中60%以上的催乳素由高分子量大催乳素组成。这些大催乳素通常具有低生物活性,但可导致血清催乳素水平的虚假增加。方法:我们报告一例由大催乳素引起的假催乳素升高。我们通过垂体MRI等检查确定血清催乳素水平升高的原因,并采用不同的检测平台和聚乙二醇(PEG)沉淀法筛选大催乳素引起的假催乳素升高的可能性。结果:无论是采用两种不同的检测平台,还是经PEG预处理后使用我们自己的检测平台,血清催乳素水平均在正常范围内。因此,根据垂体MRI阴性结果,我们认为患者血清催乳素的假性升高是由大催乳素干扰所致。结论:当血清催乳素异常升高但无相关临床症状证据时,工作人员应考虑大量催乳素干扰催乳素检测的可能性,并采取相应的纠正措施,避免对患者进行不必要的检查和治疗。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Clinical laboratory
Clinical laboratory 医学-医学实验技术
CiteScore
1.50
自引率
0.00%
发文量
494
审稿时长
3 months
期刊介绍: Clinical Laboratory is an international fully peer-reviewed journal covering all aspects of laboratory medicine and transfusion medicine. In addition to transfusion medicine topics Clinical Laboratory represents submissions concerning tissue transplantation and hematopoietic, cellular and gene therapies. The journal publishes original articles, review articles, posters, short reports, case studies and letters to the editor dealing with 1) the scientific background, implementation and diagnostic significance of laboratory methods employed in hospitals, blood banks and physicians'' offices and with 2) scientific, administrative and clinical aspects of transfusion medicine and 3) in addition to transfusion medicine topics Clinical Laboratory represents submissions concerning tissue transplantation and hematopoietic, cellular and gene therapies.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信